Jana Schaule

Nuernberg, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

The Leaky Pipeline Across Borders: A Cross-sectional Analysis of Gender Parity in Radiation Oncology in Austria and Switzerland.

The Leaky Pipeline Across Borders: A Cross-sectional Analysis of Gender Parity in Radiation Oncology in Austria and Switzerland.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: May 06, 2026

Survival and patterns of recurrence in patients with nasopharyngeal carcinoma from a non-endemic region-A German multicenter analysis.

Survival and patterns of recurrence in patients with nasopharyngeal carcinoma from a non-endemic region-A German multicenter analysis.

Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Published: March 28, 2026

Adverse Events After Metastases-Directed Stereotactic Radiotherapy and Biological Cancer Therapy.

Adverse Events After Metastases-Directed Stereotactic Radiotherapy and Biological Cancer Therapy.

Journal: JAMA network open

Published: January 14, 2026

Medial retropharyngeal lymph node involvement in nasopharyngeal cancer patients treated with radiotherapy in Germany - A multicenter analysis.

Medial retropharyngeal lymph node involvement in nasopharyngeal cancer patients treated with radiotherapy in Germany - A multicenter analysis.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: January 05, 2026

Continued versus Interrupted Targeted Therapy during Metastasis-Directed Stereotactic Radiotherapy: A Retrospective Multi-Center Safety and Efficacy Analysis.

Continued versus Interrupted Targeted Therapy during Metastasis-Directed Stereotactic Radiotherapy: A Retrospective Multi-Center Safety and Efficacy Analysis.

Journal: Cancers

Published: July 23, 2021

Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer.

Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer.

Journal: Radiation oncology (London, England)

Published: March 22, 2021

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score.

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score.

Journal: Radiation oncology (London, England)

Published: December 15, 2020

Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma.

Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma.

Journal: BJU international

Published: October 28, 2020

Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the 'TOaSTT' database.

Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the 'TOaSTT' database.

Journal: Radiation oncology (London, England)

Published: October 28, 2020

Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score.

Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score.

Journal: Radiation oncology (London, England)

Published: April 12, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026